Author:
Berwian Isabel M.,Wenzel Julia G.,Kuehn Leonie,Schnuerer Inga,Seifritz Erich,Stephan Klaas E.,Walter Henrik,Huys Quentin J. M.
Abstract
AbstractThe risk of relapse after antidepressant medication (ADM) discontinuation is high. Predictors of relapse could guide clinical decision-making, but are yet to be established. We assessed demographic and clinical variables in a longitudinal observational study before antidepressant discontinuation. State-dependent variables were re-assessed either after discontinuation or before discontinuation after a waiting period. Relapse was assessed during 6 months after discontinuation. We applied logistic general linear models in combination with least absolute shrinkage and selection operator and elastic nets to avoid overfitting in order to identify predictors of relapse and estimated their generalisability using cross-validation. The final sample included 104 patients (age: 34.86 (11.1), 77% female) and 57 healthy controls (age: 34.12 (10.6), 70% female). 36% of the patients experienced a relapse. Treatment by a general practitioner increased the risk of relapse. Although within-sample statistical analyses suggested reasonable sensitivity and specificity, out-of-sample prediction of relapse was at chance level. Residual symptoms increased with discontinuation, but did not relate to relapse. Demographic and standard clinical variables appear to carry little predictive power and therefore are of limited use for patients and clinicians in guiding clinical decision-making.
Funder
Clinical Research Priority Program “Molecular Imaging” at the University of Zurich
Rene and Susanne Braginsky Foundation
Deutsche Forschungsgemeinschaft
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. WHO. Depression and Other Common Mental Disorders: Global Health Estimates (World Health Organization, 2017).
2. Lépine, J.-P. & Briley, M. The increasing burden of depression. Neuropsychiatr. Dis. Treat. 7, 3–7 (2011).
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. (American Psychiatric Association, 2000).
4. Geddes, J. R. et al. Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review. Lancet 361, 653–61 (2003).
5. Kaymaz, N., van Os, J., Loonen, A. J. M. & Nolen, W. A. Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: A meta-analysis of placebo-controlled randomized trials. J. Clin. Psychiatry 69, 1423–36 (2008).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献